MDPI and ACS Style
Altmayer, L.A.; Lang, M.; Schleicher, J.T.; Stuhlert, C.; Wörmann, C.; Scherer, L.-S.; Thul, I.C.; Spenner, L.S.; Simon, J.A.; Wind, A.;
et al. A Plea for Monitoring Serum Selenium Levels in Breast Cancer Patients: Selenium Deficiency Is Rare during the First Year of Therapy, and Selenium Supplementation Is Associated with Elevated Risk of Overdosing. Nutrients 2024, 16, 2134.
https://doi.org/10.3390/nu16132134
AMA Style
Altmayer LA, Lang M, Schleicher JT, Stuhlert C, Wörmann C, Scherer L-S, Thul IC, Spenner LS, Simon JA, Wind A,
et al. A Plea for Monitoring Serum Selenium Levels in Breast Cancer Patients: Selenium Deficiency Is Rare during the First Year of Therapy, and Selenium Supplementation Is Associated with Elevated Risk of Overdosing. Nutrients. 2024; 16(13):2134.
https://doi.org/10.3390/nu16132134
Chicago/Turabian Style
Altmayer, Laura Alicia, Marina Lang, Julia Theresa Schleicher, Caroline Stuhlert, Carolin Wörmann, Laura-Sophie Scherer, Ida Clara Thul, Lisanne Sophie Spenner, Jana Alisa Simon, Alina Wind,
and et al. 2024. "A Plea for Monitoring Serum Selenium Levels in Breast Cancer Patients: Selenium Deficiency Is Rare during the First Year of Therapy, and Selenium Supplementation Is Associated with Elevated Risk of Overdosing" Nutrients 16, no. 13: 2134.
https://doi.org/10.3390/nu16132134
